Protein 4.1B suppresses prostate cancer progression and metastasis. - Wikidata - wikimedia - TriplyDB

Protein 4.1B suppresses prostate cancer progression and metastasis.

Protein 4.1B suppresses prostate cancer progression and metastasis.

http://www.wikidata.org/entity/Q35901782

about

FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression Protein 4.1B contributes to the organization of peripheral myelinated axons Characterization of DNA Methylation in Circulating Tumor Cells DISP3 promotes proliferation and delays differentiation of neural progenitor cells Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma.Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer.Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation.CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.GPR56 plays varying roles in endogenous cancer progression.EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.Expression of ezrin in human embryonic, fetal, and normal adult tissues.Deep intron elements mediate nested splicing events at consecutive AG dinucleotides to regulate alternative 3' splice site choice in vertebrate 4.1 genes.Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs Band 4.1 proteins regulate integrin-dependent cell spreading Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk.Cytoskeletal protein 4.1R negatively regulates T-cell activation by inhibiting the phosphorylation of LAT SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer.Role of SPARC in bone remodeling and cancer-related bone metastasis.Tumor suppressor role of protein 4.1B/DAL-1.Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.Knockout of 4.1B triggers malignant transformation in SV40T-immortalized mouse embryo fibroblast cells.A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer.Ability of PITX2 methylation to predict survival in patients with prostate cancer.Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer.EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma.DNA methylation ofPITX2predicts poor survival in men with prostate cancer Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer

P2860

Q24294440-D316D2EF-C47F-474C-B99F-1F87E5459D54 Q24339344-B1BF89F5-89FA-49FE-9FA6-C17C084B0711 Q26778427-C761E83E-4A24-4692-BC5A-E5D0D9118512 Q28116426-D6CA197D-EF02-4A3B-BE45-2805EC1331A7 Q33699391-68F21532-EE65-4ACE-B2A3-FECBDD9C3842 Q33793551-2CB151D0-CF76-466D-9752-DB3526B92075 Q33955148-9BA4EC51-73D4-4284-AC01-D15515F31F8D Q34009859-9F22821B-98BE-488C-891C-3E30B7304CA9 Q34364893-2495E613-67C6-48AE-BDE6-565F19C5CD67 Q34534040-806417DB-36F9-4A12-9EBF-6E683A9FECE5 Q34731364-E4FECDA1-D25C-49C1-9A28-F73CCB2832B4 Q35190722-4E9AA7EC-B292-4E8F-B912-046F751FBF52 Q35655790-AA14BC7C-4F29-450C-A58B-DA0E1D2EAB12 Q35681855-6B7F8E4E-1595-4CE1-BD41-B6841DA5D884 Q36023221-8669BB33-1346-4167-A514-D4DE6344D69D Q36212723-599403AB-F20F-4B67-95EB-0C68B3A43A57 Q36306266-71E3934E-1A75-4AC7-B144-8ACD0FC62D7A Q37152966-05751C35-8325-4E4F-8E48-6CB33B7C247B Q37234619-ACFF0602-F65A-4C2F-8089-0CBD7B806A63 Q37718256-05A290F8-9A71-4DC3-927D-98A09758AC0B Q38137862-147585F9-6CAC-47E6-BB2E-FE4E0AC9EACA Q38245653-ED585C81-0B2D-4DC4-8207-6ACC284FAA60 Q38736783-F1CC974A-C215-40BA-A0A1-281F138860D2 Q38757854-F08D12FC-BEF4-4BE1-8C64-8A3E46068A04 Q38764021-4160AC9A-286D-4B46-BB6E-14D619C80FDB Q38840506-125BB220-3EFE-44DF-8F39-B92CC4731A40 Q40230694-597F8A53-100F-421D-B730-2E3AB157B70D Q42362739-E93A4E3E-90B3-4EBE-9CC8-BF57F74BFFE9 Q52724780-A03E986D-BEC6-4FB3-A9C5-92491582B5E8 Q58327420-0B72F941-C64C-4813-955E-421C8A40EC55 Q58703195-92E7A199-A1C3-47EC-9560-40585BBFF10D

P2860

Protein 4.1B suppresses prostate cancer progression and metastasis.

http://www.wikidata.org/entity/Q35901782

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Protein 4.1B suppresses prostate cancer progression and metastasis.

@ast

Protein 4.1B suppresses prostate cancer progression and metastasis.

@en

type

label

Protein 4.1B suppresses prostate cancer progression and metastasis.

@ast

Protein 4.1B suppresses prostate cancer progression and metastasis.

@en

prefLabel

Protein 4.1B suppresses prostate cancer progression and metastasis.

@ast

Protein 4.1B suppresses prostate cancer progression and metastasis.

@en

P1433

Q35901782-F6F410D9-8C1B-4ACD-BA88-32CFCACEE591

P1476

Q35901782-0224785F-0913-421A-B696-1825E7E7024C

P2093

Q35901782-008E395A-F80E-4A27-803F-1C8965CC6CB1

Q35901782-1342A74C-33BF-40AB-951B-8FA67A693922

Q35901782-3B99553A-0A53-43F0-987C-2792180B1822

Q35901782-6EB080E5-F2DB-4E8F-AA0A-E6CA57EC9D14

Q35901782-715793AF-0CE9-445D-9AEA-D3888E5485F3

Q35901782-A615B271-A978-4AE5-881E-B49C3D3E822A

Q35901782-E8347365-8BC5-48C7-85E6-6159CB04150D

Q35901782-F69AB357-DB26-4532-95FA-E54B64300CBD

P2860

Q35901782-14E0DE96-BDD7-4B7A-B5F1-4A5E3D2506B2

Q35901782-19A69712-3CF6-46A7-A4B2-6AEF4E05B2CF

Q35901782-1A4213CD-AE7A-4291-A405-56F0BD05912F

Q35901782-1C85ED18-A4E1-461B-9A0F-F61B7CCBB03A

Q35901782-1E68C4DD-2F2F-4415-9C10-7573C9974F71

Q35901782-23CC61F5-E2D6-4710-BE8A-654519CA5290

Q35901782-48B5B3A0-C8E6-4748-9C54-D6C29ACF9835

Q35901782-4E47A54F-B489-48DC-9367-84CE6F25066B

Q35901782-4FA23686-1206-4C69-B237-04FE5A09BF17

Q35901782-55110077-1D7D-472A-AE98-25C432B95E47

P304

Q35901782-5EA38A8A-5B53-431A-9957-7FE2E0500E48

P31

Q35901782-299973F1-F983-4040-9FDC-D4E4C2D551DA

P356

Q35901782-500E14C8-9E6B-40F7-ADEF-7C232E791DC9

P407

Q35901782-262640CC-7536-4996-9BAA-95A2D4F5EC1D

P433

Q35901782-B7F6F80A-C702-46B8-9AF3-E54FAAE09FCD

P478

Q35901782-8FA67158-09B8-4B4D-92A2-BB1D5D9BFB8C

P50

Q35901782-B8DC2E65-0C29-4714-9561-4CB7691D3CE2

P577

Q35901782-59DB47FD-3741-49B0-B559-21B94091A429

P5875

Q35901782-BAD4CB2E-06D0-467A-BF0B-32212F6D586D

P698

Q35901782-42401517-7A27-4707-A812-A5C6B3692987

P932

Q35901782-91F86249-D936-412D-93A8-E20D768024FC

P356

PNAS.0705499104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protein 4.1B suppresses prostate cancer progression and metastasis.

@en

P2093

Charles A Whittaker

http://www.w3.org/2001/XMLSchema#string

Denise Crowley

http://www.w3.org/2001/XMLSchema#string

Herbert Haack

http://www.w3.org/2001/XMLSchema#string

Joseph L Kissil

http://www.w3.org/2001/XMLSchema#string

Marc Barry

http://www.w3.org/2001/XMLSchema#string

Roderick T Bronson

http://www.w3.org/2001/XMLSchema#string

Steven S Shen

http://www.w3.org/2001/XMLSchema#string

Sunny Y Wong

http://www.w3.org/2001/XMLSchema#string

P2860

A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer

Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability

Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression

Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas

Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation

Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells

ONCOMINE: a cancer microarray database and integrated data-mining platform

Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin

P304

12784-12789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0705499104

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6197535

http://www.w3.org/2001/XMLSchema#string

P698

17640904

http://www.w3.org/2001/XMLSchema#string

P932

1924789

http://www.w3.org/2001/XMLSchema#string